Infectious Diseases (except HIV/AIDS)

Impact of false negative results of RT-PCR test for SARS-CoV-2 in COVID-19 case count as applied to Mexico
Isaac J. Núñez, Pablo F. Belaunzarán-Zamudio, Yanink Caro-Vega

medRxiv 2020.09.17.20197038; doi: https://doi.org/10.1101/2020.09.17.20197038

Add to Selected Citations
Commercial COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays
Francisco Belda, Robin Cherenzia, Michael Crowley

medRxiv 2020.09.08.20190256; doi: https://doi.org/10.1101/2020.09.08.20190256

Add to Selected Citations
SARS-CoV-2 PCR cycle threshold at hospital admission associated with Patient Mortality
Jui Choudhuri, James Carter, Randin Nelson, Karin Skalina, Marika Osterbur-Badhey, Andrew Johnson, Doctor Y Goldstein, Monika Paroder, James Szymanski

medRxiv 2020.09.16.20195941; doi: https://doi.org/10.1101/2020.09.16.20195941

Add to Selected Citations
Metabolic stress and disease-stage specific basigin expression of peripheral blood immune cell subsets in COVID-19 patients
Peter J. Siska, Katrin Singer, Jana Klitzke, Nathalie Kauer, Sonja-Maria Decking, Christina Bruss, Carina Matos, Kristina Kolodova, Alic Peuker, Gabriele Schoenhammer, Johanna Raithel, Dirk Lunz, Bernhard Graf, Florian Geismann, Matthias Lubnow, Matthias Mack, Peter Hau, Christopher Bohr, Ralph Burkhardt, Andre Gessner, Bernd Salzberger, Frank Hanses, Florian Hitzenbichler, Daniel Heudobler, Florian Lueke, Tobias Pukrop, Wolfgang Herr, Daniel Wolff, Hendrik Poeck, Christoph Brochhausen, Petra Hoffmann, Michael Rehli, Marina Kreutz, Kathrin Renner

medRxiv 2020.09.18.20194175; doi: https://doi.org/10.1101/2020.09.18.20194175

Add to Selected Citations
Understanding SARSCOV-2 propagation, impacting factors to derive possible scenarios and simulations
Lewis E. Mehl-Madrona, Francoise Bricaire, Adrian Cuyugan, Jovan Barac, Asadullah Parvaiz, Ali Bin Jamil, Sajid Iqbal, Meryem Koliali, Ryan Vally, Mohamed Karim Sellier

medRxiv 2020.09.07.20190066; doi: https://doi.org/10.1101/2020.09.07.20190066

Add to Selected Citations
IMPACT OF UNIVERSITY RE-OPENING ON TOTAL COMMUNITY COVID-19 BURDEN
Lauren E Cipriano, Wael M R Haddara, Gregory S Zaric, Eva A Enns

medRxiv 2020.09.18.20197467; doi: https://doi.org/10.1101/2020.09.18.20197467

Add to Selected Citations
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
Tengiz Tsertsvadze, Lana Gatserelia, Marine Mirziashvili, Natia Dvali, Akaki Abutidze, Revaz Metchurtchlishvili, Carlos del Rio, Nikoloz Chkhartishvili

medRxiv 2020.09.18.20195024; doi: https://doi.org/10.1101/2020.09.18.20195024

Add to Selected Citations
Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes
Agne Ulyte, Thomas Radtke, Irene A Abela, Sarah H Haile, Jacob Blankenberger, Ruedi Jung, Celine Capelli, Christoph Berger, Anja Frei, Michael Huber, Merle Schanz, Magdalena Schwarzmueller, Alexandra Trkola, Jan Fehr, Milo A Puhan, Susi Kriemler

medRxiv 2020.09.18.20191254; doi: https://doi.org/10.1101/2020.09.18.20191254

Add to Selected Citations
Discrete SIR modelling using empirical infection data shows that SARS-CoV-2 infection provides short-term immunity
Andrew McMahon, Nicole C. Robb

medRxiv 2020.06.03.20120113; doi: https://doi.org/10.1101/2020.06.03.20120113

Add to Selected Citations
CLINICALLY DISTINCT COVID-19 CASES SHARE STRIKINGLY SIMILAR IMMUNE RESPONSE PROGRESSION: A FOLLOW-UP ANALYSIS
Melissa Hausburg, Kaysie L. Banton, Michael Roshon, David Bar-Or

medRxiv 2020.09.16.20115972; doi: https://doi.org/10.1101/2020.09.16.20115972

Add to Selected Citations

Infectious Diseases (except HIV/AIDS)

Pages